Artigo Revisado por pares

Timolol for the treatment of pyogenic granuloma (PG) in children

2016; Elsevier BV; Volume: 75; Issue: 3 Linguagem: Inglês

10.1016/j.jaad.2016.03.036

ISSN

1097-6787

Autores

Nicole Knöpfel, María del Mar Escudero‐Góngora, Ana Bauzà, A. Martín‐Santiago,

Tópico(s)

Central Venous Catheters and Hemodialysis

Resumo

Pyogenic granuloma (PG) is a rapidly growing benign vascular tumor that commonly affects children younger than 5 years of age and mainly occurs on the head and upper extremities. Clinical presentation consists of a small, friable, red papule or nodule and because of its tendency to bleed, removal of this benign vascular tumor is often sought. To avoid procedure-associated anesthesia and scarring in children, topical timolol has been proposed as a potential treatment for this condition. 1 Wine Lee L. Goff K.L. Lam J.M. Low D.W. Yan A.C. Castelo-Soccio L. Treatment of pediatric pyogenic granulomas using beta-adrenergic receptor antagonists. Pediatr Dermatol. 2014; 31: 203-207 Crossref PubMed Scopus (53) Google Scholar , 2 Malik M. Murphy R. A pyogenic granuloma treated with topical timolol. Br J Dermatol. 2014; 171: 1537-1538 Crossref PubMed Scopus (34) Google Scholar

Referência(s)